NCT02811679 A Study Of Blinatumomab For The Treatment Of Relapsed Or Refractory Indolent Non-Hodgkin Lymphoma Status TERMINATED Phase PHASE2
NCT02808403 Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan Status COMPLETED Phase N/A
NCT02807883 Blinatumomab Maintenance Following Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT02802735 Study to Evaluate the Pharmacokinetics of Single and Multiple Doses of Apremilast in Healthy Adult Male Korean Subjects Status COMPLETED Phase PHASE1
NCT02802163 Induction Therapy for Multiple Myeloma With Carfilzomib, Lenalidomide,Dexamethasone,Panobinostat Status WITHDRAWN Phase PHASE1/PHASE2
NCT02799498 Compare Actions in Healthy Volunteer of 50 mg Etanercept Injection Using an Auto-injector Device and Manual Injection Status COMPLETED Phase PHASE1
NCT02797080 Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia Status COMPLETED Phase PHASE3
NCT02792699 Study to Assess if ABP 798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis (RA) Compared to Rituximab Status COMPLETED Phase PHASE3
NCT02792517 Erenumab (AMG 334) Plus Combined Oral Contraceptive Drug Interaction Study in Healthy Females Status COMPLETED Phase PHASE1
NCT02792478 Determination of RAS Mutation Status in Liquid Biopsies in Subjects With RAS Wild-type.PERSEIDA Study Status COMPLETED Phase N/A
NCT02791516 A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With Osteoporosis Status COMPLETED Phase PHASE3
NCT02783651 An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US Status COMPLETED Phase N/A
NCT02780674 A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases Status COMPLETED Phase PHASE1
NCT02780388 A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT02779855 Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02777554 A Study to Evaluate the Pharmacokinetic Exposure of 2 Formulations of Apremilast in Healthy Adults Status COMPLETED Phase PHASE1
NCT02771860 RANKL-blockade for the Treatment of Erosive Osteoarthritis (OA) of Interphalangeal Finger Joints Status COMPLETED Phase PHASE2
NCT02756845 Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors Status COMPLETED Phase PHASE1
NCT02749370 Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast Status COMPLETED Phase PHASE4